Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / S&P PHARMAC
-
Total 13F shares
-
2,773,625
-
Share change
-
+255,479
-
Total reported value
-
$111,461,206
-
Price per share
-
$40.16
-
Number of holders
-
63
-
Value change
-
+$9,885,713
-
Number of buys
-
30
-
Number of sells
-
29
Institutional Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q3 2022
As of 30 Sep 2022,
SPDR SERIES TRUST - S&P PHARMAC (XPH) was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,773,625 shares.
The largest 10 holders included
MORGAN STANLEY, UBS Group AG, Raymond James Financial Services Advisors, Inc., BANK OF AMERICA CORP /DE/, GOLDMAN SACHS GROUP INC, LPL Financial LLC, CX Institutional, WELLS FARGO & COMPANY/MN, AMERIPRISE FINANCIAL INC, and PNC Financial Services Group, Inc..
This page lists
63
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.